Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: LaserSight

This article was originally published in The Gray Sheet

Executive Summary

LaserSight: Orlando, Florida-based firm obtains exclusive license from the University of Southern California to commercialize a device designed to improve and further automate photorefractive keratectomy (PRK) with any excimer laser. Company officials say that use of the device would obviate the need for use of a blade to remove the epithelial layer of the cornea, the procedure currently performed as a preliminary step in PRK treatment. Peter McDonnell, MD, professor of Ophthalmology at USC, developed the device with eye experts at the Los Angeles-based Doheny Eye Institute. LaserSight's development-stage Auto-PRK system will incorporate McDonnell's device...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT005067

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel